Trump admin concludes Medicare drug support

Millions of Medicare beneficiaries could face higher monthly drug costs in 2027 after the Biden administration's temporary subsidy program, which offset Part D premiums, was eliminated by the CMS. While officials claim most will see minimal increases, critics warn it may impact affordability for older adults on fixed incomes, especially ahead of midterm elections. The decision, announced this week, is expected to result in some beneficiaries paying more, with premiums potentially rising by less than $10 for many, but the full effect remains uncertain until September.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل